Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Isenberg

Showing results (221-230 of 280) with videos related to

Pageof 28
Sort By:
Lupus|October 26, 2020
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment TrendsHannah Cohen, Maria J Cuadrado, Doruk Erkan, et al.
Glycobiology|August 14, 2012
Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosusKerstin Sarter, Christina Janko, Sabine André, et al.
Arthritis Care & Research|March 31, 2021
Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems TallyChee-Seng Yee, Caroline Gordon, David A Isenberg, et al.
Rheumatology (Oxford, England)|April 28, 2009
The BILAG-2004 index is sensitive to change for assessment of SLE disease activityChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.
The Lancet. Haematology|August 30, 2016
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trialHannah Cohen, Beverley J Hunt, Maria Efthymiou, et al.
Cellular & Molecular Immunology|August 9, 2016
CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytesSoizic Garaud, Taher E Taher, Marjolaine Debant, et al.
Rheumatology (Oxford, England)|September 26, 2009
Numerical scoring for the Classic BILAG indexLynne Cresswell, Chee-Seng Yee, Vernon Farewell, et al.
Rheumatology (Oxford, England)|June 10, 2022
The BILAG-2004 index is associated with development of new damage in SLEChee-Seng Yee, Caroline Gordon, Mohammed Akil, et al.
Arthritis and Rheumatism|September 30, 2006
Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activityChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.
Arthritis and Rheumatism|February 3, 2007
The systemic lupus erythematosus Tri-Nation study: cumulative indirect costsPantelis Panopalis, Michelle Petri, Susan Manzi, et al.
Pageof 28

Showing results (221-230 of 280) with videos related to

Sort By:
Pageof 28
Lupus|October 26, 2020
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment TrendsHannah Cohen, Maria J Cuadrado, Doruk Erkan, et al.
Glycobiology|August 14, 2012
Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosusKerstin Sarter, Christina Janko, Sabine André, et al.
Arthritis Care & Research|March 31, 2021
Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems TallyChee-Seng Yee, Caroline Gordon, David A Isenberg, et al.
Rheumatology (Oxford, England)|April 28, 2009
The BILAG-2004 index is sensitive to change for assessment of SLE disease activityChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.
The Lancet. Haematology|August 30, 2016
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trialHannah Cohen, Beverley J Hunt, Maria Efthymiou, et al.
Cellular & Molecular Immunology|August 9, 2016
CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytesSoizic Garaud, Taher E Taher, Marjolaine Debant, et al.
Rheumatology (Oxford, England)|September 26, 2009
Numerical scoring for the Classic BILAG indexLynne Cresswell, Chee-Seng Yee, Vernon Farewell, et al.
Rheumatology (Oxford, England)|June 10, 2022
The BILAG-2004 index is associated with development of new damage in SLEChee-Seng Yee, Caroline Gordon, Mohammed Akil, et al.
Arthritis and Rheumatism|September 30, 2006
Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activityChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.
Arthritis and Rheumatism|February 3, 2007
The systemic lupus erythematosus Tri-Nation study: cumulative indirect costsPantelis Panopalis, Michelle Petri, Susan Manzi, et al.
Pageof 28